Home › Stargardt Disease › Florida
Pag-aaral pangklinika para sa Stargardt Disease sa Florida
8 pag-aaral para sa Stargardt Disease ang naghahanap ng mga kalahok sa mga site sa Florida.
Mga Lungsod sa Florida
Opisyal na teksto ng pag-aaral (English)
A Study of AAVB-039 in Participants With Stargardt Disease (STGD1)
- University of Florida Health Science Center, Jacksonville
Nagre-recruitPhase 1/2
Edad 8 hanggang 55 · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07161544Study of ALK-001 on the Progression of Stargardt Disease
- Vitreo Retinal Associates, Gainesville
Nagre-recruitPhase 3
Edad 8 hanggang 45 · Lahat ng kasarian · Na-update Set 18, 2026 · NCT07419334A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
- University of Florida Health - UF Health Jacksonville, Jacksonville
- University of Miami Health System - Bascom Palmer Eye Institute, Miami
Nagre-recruitObservasyonal na pag-aaral
Edad 6 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT07425574Stem Cell Ophthalmology Treatment Study II
- MD Stem Cells, Coral Springs
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT03011541Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)
- Vitreo Retinal Associates, Gainesville
Nagre-recruitObservasyonal na pag-aaral
Edad 5 pataas · Lahat ng kasarian · Na-update Mar 11, 2026 · NCT06445322Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)
- Vitreo Retinal Associates, Gainesville
- Bascom Palmer Eye Institute, Miami
Nagre-recruitPhase 1/2
Edad 12 pataas · Lahat ng kasarian · Na-update Dis 2, 2025 · NCT06467344An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene
- Vitreo Retinal Associates, Gainesville
- Bascom Palmer Eye Institute, Miami
Nagre-recruitObservasyonal na pag-aaral
Edad 12 hanggang 65 · Lahat ng kasarian · Na-update Set 19, 2025 · NCT06435000A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)
- Bascom Palmer Eye Institute, Miami
Nagre-recruitPhase 1/2
Edad 12 hanggang 65 · Lahat ng kasarian · Na-update Abr 29, 2025 · NCT06942572Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.